Secure and remarkably efficient vaccines are available for two viral STIs: hepatitis B and HPV. These vaccines have represented significant innovations in STI prevention. By the tip of 2023, the HPV vaccine had been launched as A part of schedule immunization programmes in 140countries, primarily high- and middle-revenue countries. after https://us.hc6.org/